Skip to content

The Natural History of Wheat Hypersensitivity in Thai Children

The Natural History of Wheat Hypersensitivity in Thai Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01801748
Enrollment
43
Registered
2013-03-01
Start date
2012-11-30
Completion date
2014-04-30
Last updated
2015-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child, Wheat Allergy

Keywords

wheat allergy, wheat outgrowing, wheat hypersensitivity, omega-5-gliadin, natural history of wheat hypersensitivity

Brief summary

Wheat allergy is affected 0.4-1% and is a major staple of the worldwide diet. Wheat avoidance is exceedingly difficult and imposes major dietary restriction. The purpose of this study were to determine the rate of oral tolerance and identify clinical and laboratory predictors of tolerance development in Thai children who allergic to wheat.

Detailed description

All children in this study were sensitized to wheat. Each patient was clinically evaluated, with focus on wheat allergy by both a detailed medical examination and collection of medical history. Blood sample was taken for baseline determination of ImmunoglobulinE antibodies to wheat and to omega-5-gliadin. The oral wheat challenge were performed in all study subjects to identify a case of wheat outgrowing. The primary outcome was the development of oral tolerance to wheat. Oral wheat challenge were generally performed at least every 1 years if the child did not have an interval history of symptoms with unintentional exposure.

Interventions

DIETARY_SUPPLEMENToral wheat challenge

Sponsors

National Research Council of Thailand
CollaboratorOTHER_GOV
Mahidol University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* children 1 to 15 years * History of IgE-mediated wheat allergy

Exclusion criteria

* Parents refused to sign the consent * Patient has the underlying disease: congenital heart disease, uncontrolled asthma or life-threatening condition.

Design outcomes

Primary

MeasureTime frame
The number of participants who outgrow from wheat allergy2 years

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026